Cardiology, Diabetes & Nephrology at the Limits 2023 – A review.

Written by David Jones

May 2, 2023

May 2, 2023

On Monday 17th and Tuesday 18th of April 2023 over 250 cardiologists diabetologists and nephrologists gathered at the Royal College of Physicians in London for the annual CDNATL scientific meeting.

Each year the meeting sets new standards in medical education for these closely linked disease areas, and each year the Chairs bring together an outstanding faculty of world class speakers to address this in-person meeting.

The event is supported and endorsed by our good friends at The Lancet medical journal, including the Editor-in-Chief Dr Richard Horton, and we welcome regular Chairs from UCL in London, the University of Cape Town, and Brigham and Women’s Hospital in Boston, USA.

 

Delegate feedback

In summary the delegate feedback was:

  • 100% of respondents agree the overall learning objectives of the meeting were met.
  • 98% of respondents say their overall impression of the programme was good or excellent.
  • 99% of respondents say their overall impression of the organisation was good or excellent.
  • 99% of respondents say the presented information was well balanced and consistently supported by a valid scientific evidence base.
  • 97% of respondents say there was adequate time available for discussions, questions & answers and learner engagement.
  • 100% of respondents would be interested in attending in the future.
  • 100% of respondents would recommend this meeting to colleagues.

For any international meeting of the size and scope of CDNATL, feedback 97% and 100% is exceptional. But the fact that we achieve it year after year is something particularly special and relates directly to the quality of the programme, the excellent organisation, and importantly, the vision of our funding partners who understand the benefits and need for this type of high-quality education.

 

Med-Ed hub

The presentations are being released on our Medical Education Hub (www.opendialogue.health) over the next few weeks, with the first set of four already uploaded.

But in advance of their release, we can confirm that day one of the meeting opened with a keynote presentation from Professor Dariush Mozaffarian from Tufts University in Boston. Entitled ‘The history of modern nutrition science – implications for current research, dietary guidelines and food policy’, the presentation was both highly educational and thoroughly enjoyable. Throughout the day other esteemed colleagues presented about renal protection, the pharmacology of heart failure, diabetes in older adults, PCs K9 inhibition, and asking if the new rise of pharmacological therapies means bariatric surgery has had its day.

This presentation, from Professor Rachel Batterham of University College London was designated as the annual Hatter award lecture, in memory of Sir Maurice Hatter the founder of the Hatter Cardiovascular Institute. Professor Batterham’s presentation was highly praised by the delegates and it’s already available to view on our www.opendialogue.health medical education hub.

On day two, delegates were welcomed to the event by Dr Sarah Clark, the Vice President of the Royal College of Physicians. Presentations on this day included those about atrial fibrillation, the cardio metabolic syndrome, SGLT inhibitors, cardio-renal protection, the neuroprotective effects of GLP-1 analogues, and concluded with two keynote lectures; the first being ‘The Lancet lecture’ where Professor Katherine Tuttle of the University of Washington asked ‘why is the patient with kidney disease and type 2 diabetes so different?’ , and wrapping up the event with the annual Lionel Opie memorial lecture Professor Mark Pfeffer of Brigham and Women’s Hospital in Boston talked around ‘behind the scenes of heart failure therapies -looking at evidence prior to launching the definitive outcome trials’.

Related Articles

AI in Healthcare – Dr Google will see you now

AI in Healthcare – Dr Google will see you now

'One of the key tenets of At the Limits has been to provide medical education to the widest possible audience, irrespective of global location or wealth. It’s a way in which we can contribute to the democratisation of healthcare. And that’s something that will become...

Obesity at the Limits

Obesity at the Limits

5 continents, 2 days, 1 global event     Our biggest new event for some years is now well into development and we’re pleased to announce that Obesity at the Limits will join our roster of meetings in 2025. We’ve started early as the initiative is something...

Seasons Greetings, Merry Christmas and a Happy New Year

Seasons Greetings, Merry Christmas and a Happy New Year

Two subjects this month, a quick revisit to the VPAS situation and our plans for 2024. VPAS … again The new VPAS scheme was agreed at the end of November, and although the ABPI and Pharma Industry publicly support the deal it’s difficult to realistically see it as the...